Investigation Overview
The announcement by Orthovita, Inc. that its board of directors agreed to a takeover of Orthovita by Stryker Corporation has prompted an investigation on behalf of investors of Orthovita, Inc. (NASDAQ:VITA) concerning whether the proposed acquisition is unfair to NASDAQ VITA stockholders and whether certain directors and officers breached their fiduciary duties. The investigation by...
You must register (for free) or login to view the entire investigation.